We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-8.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.03B
AUM Growth
-$263M
Cap. Flow
+$136M
Cap. Flow %
4.51%
Top 10 Hldgs %
30.94%
Holding
140
New
22
Increased
32
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$46.4M
2
POOL icon
Pool Corp
POOL
+$35.7M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$34.3M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$22M
5
LII icon
Lennox International
LII
+$14.4M

Top Sells

Rank Stock Value
1
TLND
Talend S.A. American Depositary Shares
TLND
+$26.6M
2
STLD icon
Steel Dynamics
STLD
+$22.8M
3
XPO icon
XPO
XPO
+$21.4M
4
PS
Pluralsight, Inc. Class A Common Stock
PS
+$19.6M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.23%
2 Technology 22.61%
3 Industrials 11.22%
4 Consumer Discretionary 8.19%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCYT icon
51
Veracyte
VCYT
$4.77B
$22.3M 0.74%
930,000
– –
LEA icon
52
Lear
LEA
$7.33B
$21.7M 0.72%
184,000
– –
HASI icon
53
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$20.7M 0.68%
709,800
+10,400
+1% +$290K
PFPT
54
DELISTED
Proofpoint, Inc.
PFPT
$20.4M 0.67%
158,000
– –
GWPH
55
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$20.1M 0.67%
175,000
– –
QURE icon
56
uniQure
QURE
$2.93B
$19.7M 0.65%
500,000
+240,000
+92% +$13.8M
KALV
57
DELISTED
KalVista Pharmaceuticals
KALV
$19.5M 0.64%
1,680,000
+180,000
+12% +$2.91M
AY
58
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$18.9M 0.63%
786,600
-71,900
-8% -$1.69M
TECX
59
Tectonic Therapeutic
TECX
$538M
$18.4M 0.61%
108,776
+31,368
+41% +$7.1M
RARX
60
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$17.6M 0.58%
743,000
– –
RCKT icon
61
Rocket Pharmaceuticals
RCKT
$351M
$16.5M 0.54%
1,415,000
+420,686
+42% +$5.22M
MNTA
62
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$16M 0.53%
1,236,000
– –
XPO icon
63
XPO
XPO
$23.4B
$15.7M 0.52%
636,107
-925,246
-59% -$21.4M
FOLD
64
DELISTED
Amicus Therapeutics
FOLD
$15.6M 0.52%
1,950,000
– –
OPLN
65
Openlane
OPLN
$4.29B
$15M 0.49%
610,000
– –
OKTA icon
66
Okta
OKTA
$24.4B
$14.8M 0.49%
150,000
– –
CRNX icon
67
Crinetics Pharmaceuticals
CRNX
$8.85B
$14.2M 0.47%
947,000
+143,161
+18% +$2.78M
BOLD
68
DELISTED
Audentes Therapeutics, Inc
BOLD
$14M 0.46%
499,000
– –
ISRG icon
69
Intuitive Surgical
ISRG
$126B
$13.5M 0.45%
75,000
– –
EXR icon
70
Extra Space Storage
EXR
$31.3B
$12.8M 0.42%
110,000
+30,000
+38% +$3.47M
INST
71
DELISTED
Instructure, Inc.
INST
$12.8M 0.42%
330,000
-185,000
-36% -$7.54M
ESTC icon
72
Elastic
ESTC
$6.68B
$12.4M 0.41%
+150,000
New +$13.3M
XENE icon
73
Xenon Pharmaceuticals
XENE
$6.2B
$11.5M 0.38%
1,274,100
– –
MDB icon
74
MongoDB
MDB
$26.2B
$11.1M 0.37%
+92,500
New +$13.4M
DDOG icon
75
Datadog
DDOG
$95.6B
$10.2M 0.34%
+300,000
New +$10.4M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Eventide Asset Management held 140 positions worth $3.03B, down 8% from $3.29B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $136M of net new capital in Q3 2019, opening 22 new positions and adding to 32 existing holdings. Its largest new stake was Smartsheet Inc.: 975,000 shares worth $35.1M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was XPO, an estimated $21.4M trimmed.

  • Eventide Asset Management's largest Q3 2019 buy was Smartsheet Inc.: 975,000 shares worth $35.1M.
  • Eventide Asset Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $34.3M increase.
  • Eventide Asset Management's biggest Q3 2019 reduction was XPO, cutting an estimated $21.4M.
  • Eventide Asset Management fully exited Talend S.A. American Depositary Shares in Q3 2019, selling an estimated $26.6M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $3.03B portfolio in Q3 2019.
  • Eventide Asset Management opened 22 new positions and closed 16 in Q3 2019.
  • Eventide Asset Management's portfolio value fell 8% quarter-over-quarter to $3.03B.

Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.